Corcept Therapeutics (CORT) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2026)
Corcept Therapeutics (CORT) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 58.66% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | -10.19% |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 2.65% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 24.11% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 12.18% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | -95.71% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Corcept Therapeutics | 9.56 Bn | 9.22 Bn | 162.02 Mn | 24.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.70% |
| Dec 31, 2025 | -29.71% |
| Sep 30, 2025 | -28.53% |
| Jun 30, 2025 | 59.51% |
| Mar 31, 2025 | 1,902.36% |
| Dec 31, 2024 | 1,278.97% |
| Sep 30, 2024 | 870.20% |
| Jun 30, 2024 | 256.42% |
| Mar 31, 2024 | -72.45% |
| Dec 31, 2023 | -69.19% |
| Sep 30, 2023 | -62.30% |
| Jun 30, 2023 | -52.09% |
| Mar 31, 2023 | -36.50% |
| Dec 31, 2022 | -36.83% |
| Sep 30, 2022 | -34.67% |
| Jun 30, 2022 | -39.04% |
| Mar 31, 2022 | -50.98% |
| Dec 31, 2021 | -40.18% |
| Sep 30, 2021 | -6.48% |
| Jun 30, 2021 | 128.43% |